Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen species
- 11 August 2023
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 37 (12) , e23497
Abstract
Lung cancer is one of the most common cancers in the world. Chemotherapy is a standard clinical treatment. However, tumor cells often develop multidrug resistance after chemotherapy, an inevitable bottleneck in cancer treatment. Therefore, this study used gemcitabine‐resistant (GEM‐R) CL1‐0 lung cancer cells. First, we used flow cytometry and western blot analysis to examine differences in performance between resistant and parental cells. The results showed that compared with parental cells, GEM‐R CL1‐0 cells significantly enhanced the activation of the AKT pathway, which promoted survival and growth, and decreased the activation of the reactive oxygen species‐extracellular signal‐regulated kinase (ROS)‐ERK pathway. Next, the AKT and ERK pathways' role in tumor growth was further explored in vivo using a xenograft model. The results showed that enhancing AKT and inhibiting ERK activation reduced GEM‐induced inhibition of tumor growth. Finally, combining the above results, we found that GEM‐R CL1‐0 cells showed reduced sensitivity to GEM by activating the phosphatidylinositol 3‐kinase/AKT/NF‐kB pathway and inhibiting the ROS‐ERK pathway leading to resistance against GEM. Therefore, the AKT and ERK pathways are potential targets for improving the sensitivity of cancer cells to anticancer drugs.Keywords
This publication has 32 references indexed in Scilit:
- Quantitative Proteomic Analysis of Human Lung Tumor Xenografts Treated with the Ectopic ATP Synthase Inhibitor CitreoviridinPLOS ONE, 2013
- The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase InhibitorsPLOS ONE, 2013
- Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisJournal of Lipid Research, 2013
- Quantitative Proteomics Reveals Regulation of Karyopherin Subunit Alpha-2 (KPNA2) and Its Potential Novel Cargo Proteins in Nonsmall Cell Lung CancerMolecular & Cellular Proteomics, 2012
- ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescenceThe FEBS Journal, 2009
- Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner1Acta Pharmacologica Sinica, 2008
- Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabineBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Differential regulation and properties of MAPKsOncogene, 2007
- Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A549 cellsCarcinogenesis, 2006
- Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cellsOncogene, 1999